Short Interest in TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Drops By 39.0%

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 743,600 shares, a drop of 39.0% from the October 15th total of 1,220,000 shares. Approximately 4.3% of the company’s shares are short sold. […]

Leave a Reply

Your email address will not be published.

Previous post KCM Investment Advisors LLC Purchases 173 Shares of Exxon Mobil Co. (NYSE:XOM)
Next post Umbra Applied Technologies Group, Inc. (OTCMKTS:UATG) Short Interest Update